News

Filter

Strong date from Boehringer Ingelheim and Bristol-Myers/AstraZeneca on diabetes drugs presented at ADA

29-06-2010

Continuing the string of positive news on diabetes drug developments at the ongoing 70th Scientific Sessions…

AstraZenecaBoehringer IngelheimBristol-Myers SquibbDiabeteslinagliptinOnglyzaPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top